ɫɫ

News

Aalto-born Surgify raises a €1.0M seed investment round

The Surgify Safety burr prevents the nerve and blood vessel injuries that are typically caused by other surgical drills.

A surgeon using the Surgify Safety Burr in a simulated surgery. Photo: Surgify

The technology can be easily used with existing surgical drills, and its usage does not require any additional training for the surgeon or the staff. The patent pending safety mechanism prevents the drill from damaging vital tissues, such as nerves or blood vessels. Besides neurosurgical applications, the innovation can be used in the future also in spine surgery and in the fields of orthopedics and dentistry.

“The technology has raised great interest amongst hospitals and surgeons globally. For example, we recently visited Harvard University’s teaching hospitals in Boston, and the reception was enthusiastic”, tells Visa Sippola, the CEO of Surgify.

The technology has been initially developed in cooperation between Aalto University and Department of Neurosurgery at Helsinki University Hospital. The company aims to bring the Safety Burr technology to the market in 2019. The company thereafter plans to initiate sales in the Nordic Countries, after which it will expand the business to global markets. In addition to the easy adoption process of the technology, the considerable reductions in costs and surgical complications are expected to positively affect the demand for the solution.

“Our core mission is to make bone surgery safer, as we believe that our technology has the potential to save lives in the future. The fact that we also bring clear cost savings to surgery will be of help in carrying out that mission – for example the complications caused by the current surgical drills cost over 4 billion euros each year globally”, Sippola explains.

The investors joining the startup’s second round of financing include a Finnish venture capital firm Butterfly Ventures, as well as Cascara Ventures from Belgium, Merkatura AB (Andreas Bunge) from Sweden and FRIIH GmBH (Dr. Michael Friebe) from Germany. The funding will be used to finalize the neurosurgical burr and to apply for a sales approval in Europe.

Read also:

Contact:

Visa Sippola
CEO, Surgify Medical
+358 50 353 1232
visa.sippola@surgifymedical.com

  • Updated:
  • Published:
Share
URL copied!

Read more news

Alusta pavilion. Photo: Elina Koivisto
Campus, Research & Art Published:

Alusta pavilion moved to the Aalto Campus

The giant insect hotel, Alusta pavilion invites pollinators and other species, also humans to get together.
Two students and a professor sitting around a table, talking and looking at laptop screen.
Research & Art, Studies Published:

Call for doctoral student tutors, September 2025

Sign-up to be a tutor for new doctoral students as part of the Aalto Doctoral Orientation Days!
Abstract image of glowing teal shapes and pink blocks on a striped yellow and green surface, with a dark background.
Research & Art Published:

Researchers turn energy loss into a way of creating lossless photonics-based devices

Turning energy loss from a fatal flaw into a dial for fine-tuning new states of matter into existence could yield better laser, quantum and optical technology.
ARTEFAKTI exhibition - photo: Lauriina Markkula
Cooperation, Studies Published:

ARTEFAKTI24

The second iteration of ARTEFAKTI, the graduation exhibition of Contemporary Design MA programme.